Abstract
In patients with newly diagnosed heart failure (HF), timely initiation of HF pharmacotherapeutics is imperative to arrest disease progression and reduce HF-related hospitalisation. Delays in treatment initiation however are commonplace particularly in healthcare settings with resource constraints and difficulties in establishing encounters between healthcare providers and patients. We sought to evaluate the contemporary trends in optimisation of HF therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
